Ubrogepant _ MedChemExpress (MCE)

MCE 国际站：naUbrogepantc

参考详情：Ubrogepant (MK-1602，乌布吉泮) - 仅供科研 | CGRP拮抗剂 | MCE

CAS：1374248-77-7

品牌：MedChemExpress (MCE)

存储条件：Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.

生物活性：Ubrogepant (MK-1602) 是一种新型口服降钙素基因相关肽受体 (CGRP) 拮抗剂，正在开发用于急性偏头痛的治疗[1]。 IC50 和目标：MK-1602[1]

热销产品：Olutasidenib  | GR24  | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d70  | HUHS015  | PEG6000  | Stearamide  | Alpha-2-macroglobulin, Human (sf9, His)  | Flavokawain A  | Topiramate  | Simethicone

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：CGRP Receptor

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

参考文献：

[1]. Li CC, et al. Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling. J Clin Pharmacol. 2017 Nov 14. doi: 10.1002/jcph.1021.